Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 8 hours 42 min ago
Accelerated Approval of Gene Therapies Intensifies Reimbursement Questions
Accelerated Approval of Gene Therapies Intensifies Reimbursement Questions 5/31/2023
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and More Cut Staff
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and More Cut Staff 5/31/2023
European Regulator Leaning Toward Rejecting Amylyx’s ALS Drug
European Regulator Leaning Toward Rejecting Amylyx’s ALS Drug 5/30/2023
Pfizer’s Weekly Injection Reduced Bleeding in Phase III Hemophilia Trial
Pfizer’s Weekly Injection Reduced Bleeding in Phase III Hemophilia Trial 5/30/2023
Lexicon Breaks Sotagliflozin Losing Streak with FDA Nod in Heart Failure
Lexicon Breaks Sotagliflozin Losing Streak with FDA Nod in Heart Failure 5/30/2023
AstraZeneca Touts Positive Phase III Endometrial Cancer Data for Imfinzi, Lynparza
AstraZeneca Touts Positive Phase III Endometrial Cancer Data for Imfinzi, Lynparza 5/30/2023
The Top Biotech Companies in Boston Hiring Now
The Top Biotech Companies in Boston Hiring Now 5/30/2023
Eli Lilly and Novo Nordisk Face Off in Lucrative Obesity Market
Eli Lilly and Novo Nordisk Face Off in Lucrative Obesity Market 5/30/2023
Opinion: What to Expect From an Experimental Anti-Abuse Opioid Drug
Opinion: What to Expect From an Experimental Anti-Abuse Opioid Drug 5/30/2023
ASCO: BMS Builds Case to Push Reblozyl into Frontline for MDS
ASCO: BMS Builds Case to Push Reblozyl into Frontline for MDS 5/26/2023
ASCO: Merck Previews Keytruda’s Wins in Renal, Cervical Cancer
ASCO: Merck Previews Keytruda’s Wins in Renal, Cervical Cancer 5/26/2023
ASCO: Regeneron Touts New Data in Bid to Become Next Big LAG-3 Player
ASCO: Regeneron Touts New Data in Bid to Become Next Big LAG-3 Player 5/26/2023
Apellis Drops ALS Candidate After Disappointing Phase II Results
Apellis Drops ALS Candidate After Disappointing Phase II Results 5/25/2023
Mirati’s Sitravatinib Fails in Phase III Lung Cancer Trial, Nixes Development
Mirati’s Sitravatinib Fails in Phase III Lung Cancer Trial, Nixes Development 5/25/2023
BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment
BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment 5/25/2023
Annexon Sets Sights on Phase III Geographic Atrophy Trial Despite Missing Mid-Stage Mark
Annexon Sets Sights on Phase III Geographic Atrophy Trial Despite Missing Mid-Stage Mark 5/25/2023
Braeburn’s Long-Acting Brixadi Receives FDA Clearance to Treat Opioid Use Disorder
Braeburn’s Long-Acting Brixadi Receives FDA Clearance to Treat Opioid Use Disorder 5/25/2023
What People with Autism Wish Their Employers Knew
What People with Autism Wish Their Employers Knew 5/25/2023
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits 5/24/2023
Moving From the Bench to Management: How to Become an Effective Leader
Moving From the Bench to Management: How to Become an Effective Leader 5/24/2023
World Pharma News
- Bayer launches unit to develop new precision health consumer products
- Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine
- New blood biomarker can predict if cognitively healthy elderly will develop Alzheimer's disease
- Large study provides scientists with deeper insight into long COVID symptoms
- Pfizer's PAXLOVID™ receives FDA approval for adult patients at high risk of progression to severe COVID-19